×
Please click
here
if you are not redirected within a few seconds.
All
Images
News
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Did you mean:
Cogent
Comms
Cogent Communications Offers $206 Million in Secured Notes Backed by IPv4 Addresses
CircleID
Cogent (CCOI) recently announced that it was offering secured notes for $206M. The unusual part is what it's using as security: some of its...
2 days ago
Cogent Communications CEO to Present at Three Upcoming Conferences
Yahoo Finance Canada
Cogent Communications Holdings, Inc.("Cogent") (NASDAQ: CCOI), one of the largest Internet service providers in the world, today announced...
5 days ago
Cogent Communications Launches $206M IPv4-Backed Note Offering - TipRanks.com
Tipranks
An update from Cogent Communications (CCOI) is now available. Cogent Communications Holdings, Inc. is planning to offer approximately $206 million in...
2 weeks ago
Cogent Communications (NASDAQ:CCOI) Downgraded by StockNews.com to Sell
Defense World
Read Cogent Communications (NASDAQ:CCOI) Downgraded by StockNews.com to Sell at Defense World.
1 week ago
Cogent Biosciences Announces Poster Presentations at Upcoming San Antonio Breast Cancer Symposium
GlobeNewswire
WALTHAM, Mass. and BOULDER, Colo., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company...
5 months ago
Fox anchor calls Sununu ‘snarky’ for quip about Trump’s age
The Hill
Fox News host Harris Faulkner and New Hampshire Gov. Chris Sununu (R) sparred Tuesday over former President Trump's age.
3 months ago
Cogent Communications Reports Third Quarter 2023 Results and Increases its Regular Quarterly Dividend on its ...
PR Newswire
Financial and Business Highlights Service revenue increased from Q2 2023 to Q3 2023 by 14.9% to $275.4 million and increased from Q3 2022 to...
5 months ago
StockNews.com Upgrades Cogent Communications (NASDAQ:CCOI) to Hold
Defense World
Read StockNews.com Upgrades Cogent Communications (NASDAQ:CCOI) to Hold at Defense World.
2 weeks ago
Cogent Biosciences Announces Positive Part 1b Data from SUMMIT Trial Evaluating Bezuclastinib in Patients with ...
GlobeNewswire
Registration-enabling SUMMIT Part 2 initiated and actively enrolling at 40 sites globally; RP2D selected at 100 mg once-daily optimized...
2 months ago
Cogent Biosciences Announces Positive Initial Data from Phase 2 SUMMIT Trial Evaluating Bezuclastinib in Patients ...
GlobeNewswire
Rapid and ongoing improvement in patient symptoms, with 57% median best improvement on MC-QoL and 78% of patients reporting ≥1 point...
4 months ago